Home page Home page

Nespo
darbepoetin alfa

PACKAGE LEAFLET: INFORMATION FOR THE USER


Nespo 10 micrograms solution for injection in a pre-filled syringe Nespo 15 micrograms solution for injection in a pre-filled syringe Nespo 20 micrograms solution for injection in a pre-filled syringe Nespo 30 micrograms solution for injection in a pre-filled syringe Nespo 40 micrograms solution for injection in a pre-filled syringe Nespo 50 micrograms solution for injection in a pre-filled syringe Nespo 60 micrograms solution for injection in a pre-filled syringe Nespo 80 micrograms solution for injection in a pre-filled syringe Nespo 100 micrograms solution for injection in a pre-filled syringe Nespo 130 micrograms solution for injection in a pre-filled syringe Nespo 150 micrograms solution for injection in a pre-filled syringe Nespo 300 micrograms solution for injection in a pre-filled syringe Nespo 500 micrograms solution for injection in a pre-filled syringe darbepoetin alfa


Please read this leaflet carefully before you start using this medicine.


Keep this leaflet. You may need to read it again.


If you have any further questions, ask your doctor, nurse or pharmacist.


This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.


Medicinal product no longer authorised

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist.


In this leaflet


  1. What Nespo is and what is it used for

  2. Before you use Nespo

  3. How to use Nespo

  4. Possible side effects

  5. How to store Nespo

  6. Further information

  7. Instructions for injecting with the Nespo pre-filled syringe


  1. WHAT NESPO IS AND WHAT IS IT USED FOR


    Your doctor has given you Nespo (an anti-anaemic) to treat your anaemia. Anaemia is when your blood does not contain enough red blood cells and the symptoms may be fatigue, weakness and shortness of breath.


    Nespo works in exactly the same way as the natural hormone erythropoietin. Erythropoietin is produced in your kidneys and encourages your bone marrow to produce more red blood cells. The active substance of Nespo is darbepoetin alfa produced by gene-technology in Chinese Hamster Ovary Cells (CHO-K1).


    If you have chronic renal failure


    Nespo is used to treat symptomatic anaemia that is associated with chronic renal failure (kidney failure) in adults and children. In kidney failure, the kidney does not produce enough of the natural hormone erythropoietin which can often cause anaemia.

    Because it will take your body some time to make more red blood cells, it will be about four weeks before you notice any effect. Your normal dialysis routine will not affect the ability of Nespo to treat your anaemia.


    If you are receiving chemotherapy


    Nespo is used to treat symptomatic anaemia in adult cancer patients with non-bone marrow cancers (non-myeloid malignancies) who are receiving chemotherapy.


    One of the main side effects of chemotherapy is that it stops the bone marrow producing enough blood cells. At first, only white blood cells seem to be affected. This is because the red blood cells have a much longer life span in the circulating blood. Towards the end of your chemotherapy course, particularly if you have had a lot of chemotherapy, your red blood cell count may fall making you anaemic.


  2. BEFORE YOU USE NESPO


    DO NOT use Nespo:


    • if you have been diagnosed with high blood pressure which is not being controlled with other medicines prescribed by your doctor; or


      Medicinal product no longer authorised

    • if you are allergic to Nespo (darbepoetin alfa), r-HuEPO or to any of the other ingredients in Nespo.


      Take special care with Nespo


      Please tell your doctor if you are suffering or have suffered from:


    • high blood pressure which is being controlled with medicines prescribed by your doctor;


    • sickle cell anaemia;


    • epileptic fits (seizures);


    • convulsions (fits or seizures);


    • liver disease;


    • significant lack of response to drugs used to treat anaemia; or


    • an allergy to latex (the needle cover on the pre-filled syinge contains a derivative of latex).


      Special warnings


    • If you have symptoms which include unusual tiredness and a lack of energy this could mean you have pure red cell aplasia (PRCA), which has been reported in patients. PRCA means that the body has stopped or reduced the production of red blood cells which causes severe anaemia. If you experience these symptoms you should contact your doctor who will determine the best course of action to treat your anaemia.


    • Your doctor should try to keep your haemoglobin between 10 and 12 g/dl.

    • If you have chronic renal failure there is an increased risk of serious problems with your heart or blood vessels (cardiovascular events) if your haemoglobin is kept too high.


    • If you are a cancer patient you should be aware that Nespo may act as a blood cell growth factor and in some circumstances may have a negative impact on your cancer. Depending on your individual situation a blood transfusion may be preferable. Please discuss this with your doctor.


    • Misuse by healthy people can cause life-threatening problems with the heart or blood vessels.


      Using other medicines


      Cyclosporin and tacrolimus may be affected by the number of red cells in your blood. It is important to tell your doctor if you are taking either of these drugs.


      Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.


      Using Nespo with food and drink Food and drink do not affect Nespo. Pregnancy and breast-feeding

      Nespo has not been tested in pregnant women. It is important to tell your doctor if you:


      Medicinal product no longer authorised

    • are pregnant;


    • think you may be pregnant; or


    • plan to get pregnant.


    It is not known whether darbepoetin alfa is excreted in human milk. You must stop breast-feeding if you use Nespo.


    Driving and using machines


    Nespo should not affect your ability to drive or use machinery.


  3. HOW TO USE NESPO


    Following blood tests, your doctor has decided you need Nespo as your haemoglobin level is 10 g/dl or less. Your doctor will tell you how much and how often you must take Nespoin order to maintain a haemoglobin level between 10 and 12 g/dl. This may vary depending on whether you are an adult or a child.


    Injecting Nespo yourself


    Your doctor may decide that it is best for you or a carer to inject Nespo. Your doctor, nurse or pharmacist will show you how to inject yourself with the pre-filled syringe. Do not try to inject yourself if you have not been trained. Never inject Nespo into a vein yourself.


    If you have chronic renal failure


    Nespo is given as a single injection, either once a week, once every two weeks, or once every month either under your skin (subcutaneous) or into a vein (intravenous).

    In order to correct your anaemia, your initial dose of Nespo per kilogram of your body weight will be either:

    • 0.75 micrograms once every two weeks, or

    • 0.45 micrograms once weekly

      Your doctor will take regular blood samples to measure how your anaemia is responding and may adjust your dose once every four weeks as necessary.


      Once your anaemia is corrected, your doctor will continue to regularly check your blood and your dose may be adjusted further in order to maintain long-term control of your anaemia. Your doctor will inform you if your dose changes.


      Your blood pressure will also be checked regularly, particularly at the beginning of your treatment. In some cases, your doctor may recommend that you take iron supplements.

      Your doctor may decide to change the way that your injection is given (either under the skin or into a vein). If this changes you will start on the same dose as you have been receiving and your doctor will take blood samples to make sure that your anaemia is still being managed correctly.


      If your doctor has decided to change your treatment from r-HuEPO (erythropoietin produced by gene- technology) to Nespo, they will choose whether you should receive your Nespo injection once weekly or once every two weeks. The route of injection is the same as with r-HuEPO but your doctor will tell you how much you should take, and when, and may adjust your dose if necessary.


      If you are receiving chemotherapy

      Medicinal product no longer authorised

      Nespo is given as a single injection, either once a week or once every three weeks, under your skin. In order to correct your anaemia, your initial dose will be

    • 500 micrograms once every three weeks (6.75 micrograms of Nespo per kilogram of your body

      weight), or

    • 2.25 micrograms (once weekly) of Nespo per kilogram of your body weight.

    Your doctor will take regular blood samples to measure how your anaemia is responding and may adjust your dose as necessary. Your treatment will continue until approximately four weeks after the end of your chemotherapy. Your doctor will tell you exactly when to stop taking Nespo.


    In some cases, your doctor may recommend that you take iron supplements.


    If you use more Nespo than you should


    You should have no serious problems if you take more Nespo than you need. However, you should contact your doctor, nurse or pharmacist if this does happen. If you feel unwell in any way you should contact your doctor, nurse or pharmacist immediately.


    If you forget to inject Nespo


    If you have forgotten a dose of Nespo, you should contact your doctor to discuss when you should inject the next dose.


  4. POSSIBLE SIDE EFFECTS


    Like all medicines, Nespo may cause side effects, although not everybody gets them. The following side effects have been experienced by some patients taking Nespo:

    Very Common (seen in more than 10 in 100 people)


    • High blood pressure (hypertension)

    • Fluid retention (oedema)


      Common (seen in more than 1 in 100 people)


    • Blood clots (thrombosis)

    • Pain around the area injected

    • Rash and/or redness of the skin


      Rare (seen in more than 1 in 10,000 people)


      Serious allergic reactions which may include:

    • Sudden life-threatening allergic reactions (anaphylaxis)

    • Swelling of the face, lips, mouth, tongue or throat which may cause difficulty in swallowing or breathing (angioedema)

    • Shortness of breath (dyspnoea)

    • Skin rash

    • Hives (urticaria)


      Very rare (seen in less than 1 in 10,000 people)


      Medicinal product no longer authorised

    • Pure red cell aplasia (PRCA) – (anaemia, unusual tiredness, lack of energy) Convulsions (fits and seizures) have been reported in patients treated with Nespo.

      If you have any of these symptoms or you notice any side effects that are not mentioned in this leaflet, please tell your doctor, nurse or pharmacist.


  5. HOW TO STORE NESPO


    Keep out of the reach and sight of children. Keep in the original package in order to protect from light.

    Store in a refrigerator (2°C – 8°C). Do not freeze. Do not use Nespo if you think it has been frozen. When your syringe has been removed from the refrigerator and left at room temperature for

    approximately 30 minutes before injection it must either be used within 7 days or disposed of.


    Do not use Nespo after the expiry date which is stated on the carton and on the pre-filled pen label after EXP. The expiry date refers to the last day of that month.


    Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.


  6. FURTHER INFORMATION


    What Nespo contains


    Nespo comes in a pre-filled syringe that contains either 10, 15, 20, 30, 40, 50, 60, 80, 100, 130, 150, 300 or 500 micrograms of the active substance darbepoetin alfa.

    Nespo also contains sodium phosphate monobasic, sodium phosphate dibasic, sodium chloride, polysorbate 80 and water for injections.


    What Nespo looks like and contents of the pack


    Nespo is a clear, colourless or slightly pearly liquid. If it is cloudy or there are particles in it, you must not use it.


    Nespo is available in packs of 1 or 4 pre-filled syringes (not all pack sizes may be marketed). The syringes are provided either with (1-& 4-pack) or without (1-pack) a blister-wrapping.


    Marketing Authorisation Holder: Dompé Biotec S.p.A.

    Via San Martino 12 I-20122 Milan

    Italy


    Manufacturer: Amgen Europe B.V. Minervum 7061

    NL-4817 ZK Breda

    The Netherlands


    Further information


    Medicinal product no longer authorised

    If you want more information about this medicine, please contact the local representative of the company that is authorised to market Nespo.


    This leaflet was last approved in .


    https://www.emea.europa.eu/


    image


  7. INSTRUCTIONS FOR INJECTING WITH THE NESPO PRE-FILLED SYRINGE


This section contains information on how to give yourself an injection of Nespo. It is important that you do not try to give yourself the injection unless you have received training from your doctor, nurse or pharmacist. If you have questions about how to inject, please ask your doctor, nurse or pharmacist for assistance.


How do you or the person injecting you, use the Nespo pre-filled syringe?


Your doctor has prescribed an Nespo pre-filled syringe for injection into the tissue just under the skin. Your doctor, nurse, or pharmacist will tell you how much Nespo you need and how frequently it should be injected.


Equipment:


To give yourself an injection you will need: